AdaptHealth (AHCO) to Release Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO – Get Rating) is scheduled to post its quarterly earnings results before the market opens on Tuesday, August 9th. Analysts expect AdaptHealth to post earnings of $0.32 per share for the quarter. AdaptHealth has set its FY 2022 guidance at EPS.Individual that wish to listen to the company’s earnings conference call can do so using this link.

AdaptHealth (NASDAQ:AHCO – Get Rating) last posted its quarterly earnings data on Tuesday, May 10th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.23). The business had revenue of $706.20 million during the quarter, compared to analyst estimates of $646.42 million. AdaptHealth had a net margin of 7.54% and a return on equity of 7.77%. The company’s revenue for the quarter was up 46.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.17 earnings per share. On average, analysts expect AdaptHealth to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

AdaptHealth Trading Up 0.9 %

NASDAQ AHCO opened at $22.30 on Tuesday. The company has a debt-to-equity ratio of 1.03, a quick ratio of 1.16 and a current ratio of 1.39. The firm has a market cap of $2.99 billion, a PE ratio of 40.55, a P/E/G ratio of 0.31 and a beta of 0.52. AdaptHealth has a one year low of $11.40 and a one year high of $28.75. The firm’s fifty day moving average is $18.87 and its two-hundred day moving average is $17.22.

Insiders Place Their Bets

In related news, Director Aero Holdings Ii Ll Skyknight bought 100,000 shares of the stock in a transaction on Thursday, June 16th. The shares were bought at an average cost of $16.78 per share, for a total transaction of $1,678,000.00. Following the completion of the transaction, the director now owns 200,000 shares of the company’s stock, valued at approximately $3,356,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Aero Holdings Ii Ll Skyknight bought 100,000 shares of the stock in a transaction on Thursday, June 16th. The shares were bought at an average cost of $16.78 per share, for a total transaction of $1,678,000.00. Following the completion of the transaction, the director now owns 200,000 shares of the company’s stock, valued at approximately $3,356,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Skyknight Capital Fund Ii, L.P purchased 35,091 shares of AdaptHealth stock in a transaction on Wednesday, June 1st. The stock was acquired at an average cost of $17.57 per share, for a total transaction of $616,548.87. Following the acquisition, the director now directly owns 2,929,134 shares of the company’s stock, valued at $51,464,884.38. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 350,390 shares of company stock worth $6,016,723. 17.30% of the stock is owned by company insiders.

Institutional Trading of AdaptHealth

Institutional investors and hedge funds have recently modified their holdings of the business. Prudential Financial Inc. increased its position in AdaptHealth by 370.1% during the first quarter. Prudential Financial Inc. now owns 118,362 shares of the company’s stock worth $1,897,000 after purchasing an additional 93,182 shares during the last quarter. Verition Fund Management LLC increased its position in AdaptHealth by 38.5% during the first quarter. Verition Fund Management LLC now owns 264,796 shares of the company’s stock worth $4,245,000 after purchasing an additional 73,576 shares during the last quarter. Graham Capital Management L.P. acquired a new position in AdaptHealth during the first quarter worth approximately $945,000. State Street Corp increased its position in shares of AdaptHealth by 3.7% in the first quarter. State Street Corp now owns 1,599,838 shares of the company’s stock worth $25,645,000 after acquiring an additional 56,645 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of AdaptHealth by 6.3% in the first quarter. Northern Trust Corp now owns 767,565 shares of the company’s stock worth $12,305,000 after acquiring an additional 45,472 shares in the last quarter. Hedge funds and other institutional investors own 83.68% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Canaccord Genuity Group dropped their price objective on shares of AdaptHealth from $29.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday, May 12th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of AdaptHealth from $28.00 to $22.00 in a research note on Wednesday, May 11th. Truist Financial boosted their price target on shares of AdaptHealth from $20.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, July 14th. Finally, TheStreet lowered shares of AdaptHealth from a “c-” rating to a “d+” rating in a research note on Friday, April 29th. Four research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $24.67.

About AdaptHealth

(Get Rating)

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Read More

• Get a free copy of the StockNews.com research report on AdaptHealth (AHCO)
• MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
• The Colgate-Palmolive Growth Outlook Brightens 
• Deep Value High Yield Newell Brands Is Ready To Bottom 
• These Stocks Outperformed Last Time There Was A Recession
• Does Rivian’s Stock Still Have A Future?

Want More Great Investing Ideas?